Skip to search formSkip to main contentSkip to account menu

MenAfriVac

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Meningococcal vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys
2016
2016
Incidence and types of adverse events during mass vaccination campaign with the meningococcal a conjugate vaccine (MENAFRIVAC™) in Cameroon
A new vaccine against meningitis A was introduced in Africa meningitis belt in 2010. This study was planned to describe the… 
Review
2015
Review
2015
Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub… 
Review
2015
Review
2015
[Study of the immunization coverage determinants of vaccination campaign against meningococcal A meningitis in Burkina Faso].
Review
2015
Review
2015
Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso
Background. Five years since the successful introduction of MenAfriVac in a mass vaccination campaign targeting 1- to 29-year… 
2015
2015
Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and… 
2014
2014
A field based evaluation of adverse events following MenAfriVac®vaccine delivered in a controlled temperature chain (CTC) approach in Benin
Introduction An estimated one hundred million African meningitis belt residents have received MenAfriVac®meningococcal serogroup… 
Review
2013
Review
2013
From Agadez to Zinder: estimating coverage of the MenAfriVac™ conjugate vaccine against meningococcal serogroup A in Niger, September 2010 - January 2012.
2012
2012
Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso.
Review
2012
Review
2012
Whom and Where Are We Not Vaccinating? Coverage after the Introduction of a New Conjugate Vaccine against Group A Meningococcus in Niger in 2010
MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African “meningitis belt”. In… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)